CON group | DV group | DT group | P values | |
SRS (T8) | 4 (3–4) | 4 (4–5) | 4 (4–5) | 0.001 |
4 (3–4) | 4 (4–5) | 0.005 | ||
4 (3–4) | 4 (4–5) | 0.000 | ||
SRS (T9) | 5 (4–5) | 5 (4–5) | 5 (5–5) | 0.001 |
5 (4–5) | 5 (4–5) | 0.005 | ||
5 (4–5) | 5 (5–5) | 0.000 | ||
SRS (T10) | 6 (5–6) | 6 (6–6) | 6 (6–6) | 0.323 |
6 (5–6) | 6 (6–6) | 0.139 | ||
6 (5–6) | 6 (6–6) | 0.394 | ||
VAS (T8) | 3.4 (0.6) | 2.6 (0.8) | 2.8 (0.8) | 0.000 |
3.4 (0.6) | 2.6 (0.8) | 0.000 | ||
3.4 (0.6) | 2.8 (0.8) | 0.005 | ||
VAS (T9) | 3.1 (0.6) | 2.6 (0.7) | 2.7 (0.7) | 0.015 |
3.1 (0.6) | 2.6 (0.7) | 0.005 | ||
3.1 (0.6) | 2.7 (0.7) | 0.038 | ||
VAS (T10) | 3.2 (0.6) | 2.9 (0.7) | 2.6 (0.8) | 0.009 |
3.2 (0.6) | 2.9 (0.7) | 0.1 | ||
3.2 (0.6) | 2.6 (0.8) | 0.002 |
Values are expressed as mean (SD) or median (IQR). The SRS was determined according to consciousness (3=awake, 2=responds to verbal stimuli, 1=responds to tactile stimuli, 0=not responding), airway condition (2=cough on command or cry, 1=maintains good airway, 0=requires airway assistance) and motor condition (2=moves limbs purposefully, 1=non-purposeful movement, 0=not moving). The VAS score was defined on a scale of 0 (no pain) to 10 (the worst pain imaginable).
CON group, patients were intravenously injected with saline (20 mL) for 10 min; DT group, Dex (0.5 µg/kg, diluted in 1 mL saline) was sprayed down the patient’s intratracheal tube; DV group, patients were intravenously given Dex (0.5 µg/kg, diluted in 20 mL saline) for 10 min; SRS, Steward recovery score; VAS, visual analogue scale.